1-20 of 48
Julianne Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Post-Transplant Cyclophosphamide (PTCy) with or without MMF in the Prevention of De Novo and Progressive / Relapsing Chronic Graft-Versus-Host Disease after HLA-Matched Donor Transplant

Rima M. Saliba, Curtis Marcoux, Amin Alousi, Gabriela Rondon, Julianne Chen, May Daher, MD, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta
Journal: Blood
Blood (2023) 142 (Supplement 1): 2188.
https://doi.org/10.1182/blood-2023-188108
Published: 2023
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of Outcomes and Contemporary Trends Spanning 10 Years

Alexandre Bazinet, Hagop Kantarjian, Naszrin Arani, Uday R. Popat, Courtney D. DiNardo, Naval Daver, Musa Yilmaz, Hussein A. Abbas, Nicholas Short, Ghayas C. Issa, Elias Jabbour, Sherry A. Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia-Manero, Amin M. Alousi, Elizabeth J. Shpall, Richard E. Champlin, Gautam Borthakur, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2022) 140 (Supplement 1): 4872–4875.
https://doi.org/10.1182/blood-2022-162962
Published: 2022
Journal Articles

Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections

Jeremy L. Ramdial, Rima M. Saliba, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Elizabeth J. Shpall, Roy Chemaly, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2855.
https://doi.org/10.1182/blood-2021-153997
Published: 2021
Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134858
Published: 2020
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Brief Report
Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin
Journal: Blood
Blood (2020) 135 (6): 449–452.
https://doi.org/10.1182/blood.2019003662
Published: 2020
Includes: Supplemental data
Journal Articles

Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis

Stefan O. Ciurea, MD, Ankur Varma, MD, Piyanuch Kongtim, MD, Samer Srour, Qaiser Bashir, MBBS, Amin M. Alousi, MD, Rohtesh S. Mehta, MD, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, MD, Gabriela Rondon, MD, Julianne Chen, Amanda L. Olson, MD, Marina Y Konopleva, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 42.
https://doi.org/10.1182/blood-2019-123699
Published: 2019
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD, Roland Bassett, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar Qazilbash, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 256.
https://doi.org/10.1182/blood-2019-122124
Published: 2019
Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Richard E. Champlin, MD, Uday Popat, MD, Betul Oran, MDMS, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Issa F. Khouri, MD, Chitra Hosing, MD, Paolo Anderlini, Roy B Jones, MD PhD, David Marin, MD, Rohtesh Mehta, MD, Yago Nieto, MD PhD, Amanda L. Olson, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elizabeth J. Shpall, MD, Julianne Chen, Gabriela Rondon, MD, Becky McMullin, Vivian P Al Jahdhami, RN, Jitesh Kawedia, BPharm, Benigno C. Valdez, PhD, Junsheng Ma, MS, Peter F Thall, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 257.
https://doi.org/10.1182/blood-2019-124921
Published: 2019
Journal Articles

Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receiving Myeloablative Fractionated Busulfan Conditioning Regimen

Uday Popat, MD, Rima M. Saliba, PhD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Gabriela Rondon, MD, Glenda Woodworth, BSN, OCN, RN, Becky McMullin, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar H. Qazilbash, MD, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3296.
https://doi.org/10.1182/blood-2019-125996
Published: 2019
Journal Articles

Timed Sequential Busulfan and Post-Transplantation Cyclophosphamide in Matched and Haploidentical Transplantation: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD MPH, MS, Roland L. Bassett, Jr., Amanda L. Olson, MD, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Paolo Anderlini, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Katy Rezvani, MD PhD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Richard E Champlin, MD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3373.
https://doi.org/10.1182/blood-2018-99-113439
Published: 2018
Journal Articles

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Stefan O. Ciurea, Maria Cecilia Borges Bittencourt, MD, Denái R. Milton, Kai Cao, MS, MD, Piyanuch Kongtim, MD, Gabriela Rondon, MD, Julianne Chen, Marina Y. Konopleva, MD PhD, Jorge M. Ramos Perez, Mohammed Elshazly, MD MSc, Majdi Aljadayeh, MD, Michele Alvarez, Jin S Im, MD PhD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Uday Popat, MD, Qaiser Bashir, MD MBBS, Betul Oran, MD MS, Chitra Hosing, MD, Issa F. Khouri, Partow Kebriaei, MD, Richard E Champlin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3450.
https://doi.org/10.1182/blood-2018-99-111606
Published: 2018
Journal Articles

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Jorge M. Ramos Perez, MD, Gabriela Rondon, MD, Julianne Chen, Abhishek R Chilkulwar, Gheath Alatrash, DO, PhD, Amin M. Alousi, MD, Borje S Andersson, MD PhD, Jin S Im, MD PhD, Chitra Hosing, MD, Qaiser Bashir, MD MBBS, Issa F. Khouri, Partow Kebriaei, MD, Betul Oran, MD MS, Uday Popat, MD, Richard E Champlin, MD, Stefan O. Ciurea
Journal: Blood
Blood (2018) 132 (Supplement 1): 2141.
https://doi.org/10.1182/blood-2018-99-111639
Published: 2018
Journal Articles

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Clinical Trials & Observations
Stefan O. Ciurea, Abhishek Chilkulwar, Rima M. Saliba, Julianne Chen, Gabriela Rondon, Keyur P. Patel, Haitham Khogeer, Abdul R. Shah, Brion V. Randolph, Jorge M. Ramos Perez, Uday Popat, Chitra M. Hosing, Qaiser Bashir, Rohtesh Mehta, Gheath Al-Atrash, Jin Im, Issa F. Khouri, Partow Kebriaei, Richard E. Champlin
Journal: Blood
Blood (2018) 131 (26): 2989–2992.
https://doi.org/10.1182/blood-2018-02-832360
Published: 2018
Journal Articles

Proteomic Profiling Identifies c-KIT and 53BP1 As Resistance Factors of AML Relapse Post Allogeneic Stem Cell Transplantation with G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning

Zhihong Zeng, MD, Hongbo Lu, MD, Rui-Yu Wang, MD, Wenbin Lu, PhD, Julianne Chen, Christopher B Benton, MD, Keith Baggerly, PhD, Elizabeth J Shpall, MD, Richard E Champlin, MD, Marina Konopleva, MD PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2528.
https://doi.org/10.1182/blood.V130.Suppl_1.2528.2528
Published: 2017
Journal Articles

Allogeneic Transplantation for TP53+ AML: Prognostic Factors for Survival

Stefan O. Ciurea, Rima M. Saliba, PhD, Julianne Chen, Gabriela Rondon, MD, Uday Popat, MD, Simrit Parmar, MBBS, Borge Anderson, Amin M. Alousi, MD, Sairah Ahmed, Qaiser Bashir, MD MBBS, Gheath Alatrash, DO, PhD, Chitra Hosing, Amanda L. Olson, MD, Rohtesh S. Mehta, MDMPH,MS, Katayoun Rezvani, MD PhD, Elizabeth J Shpall, MD, Issa F. Khouri, Partow Kebriaei, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1938.
https://doi.org/10.1182/blood.V130.Suppl_1.1938.1938
Published: 2017
Journal Articles

Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Gabriela Rondon, MD, Julianne Chen, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, Qaiser Bashir, MD MBBS, Partow Kebriaei, MD, Issa F. Khouri, Richard E. Champlin, MD, Stefan O. Ciurea
Journal: Blood
Blood (2017) 130 (Supplement 1): 4511.
https://doi.org/10.1182/blood.V130.Suppl_1.4511.4511
Published: 2017
Journal Articles

Fludarabine Melphalan Conditioning Followed By T-Replete Haplo Identical (Haplo) Transplantation or Haplo Cord (HC) Transplantation

Koen Van Besien, MD PhD, Andrew Artz, MD, Richard E Champlin, MD, Danielle Guarneri, Michael R. Bishop, MD, Julianne Chen, Tsiporah B. Shore, MD, Hongtao Liu, MD PhD, Gabriela Rondon, MD, Sebastian A. Mayer, MD, Stefan O. Ciurea
Journal: Blood
Blood (2017) 130 (Supplement 1): 3328.
https://doi.org/10.1182/blood.V130.Suppl_1.3328.3328
Published: 2017
Journal Articles

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Clinical Trials & Observations
Stefan O. Ciurea, Jolie R. Schafer, Roland Bassett, Cecele J. Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur, Alison Gulbis, Sairah Ahmed, Katayoun Rezvani, Elizabeth J. Shpall, Dean A. Lee, Richard E. Champlin
Journal: Blood
Blood (2017) 130 (16): 1857–1868.
https://doi.org/10.1182/blood-2017-05-785659
Published: 2017
Includes: Supplemental data